Back to Journals » Cancer Management and Research » Volume 13

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Total article views   HTML views PDF downloads Totals
4,179 Dovepress* 3,815+ 350 4,165
PubMed Central* 364 173 537
Totals 4,179 523 4,702
*Since 14 September 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar